Myeloproliferative Neoplasms Critical Concepts and Management /

Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelo...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Barbui, Tiziano. (Editor, http://id.loc.gov/vocabulary/relators/edt), Tefferi, Ayalew. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012.
Edition:1st ed. 2012.
Series:Hematologic Malignancies,
Subjects:
Online Access:https://doi.org/10.1007/978-3-642-24989-1
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03680nam a22005295i 4500
001 978-3-642-24989-1
003 DE-He213
005 20200706035546.0
007 cr nn 008mamaa
008 120109s2012 gw | s |||| 0|eng d
020 |a 9783642249891  |9 978-3-642-24989-1 
024 7 |a 10.1007/978-3-642-24989-1  |2 doi 
050 4 |a RB45 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
072 7 |a MJF  |2 thema 
082 0 4 |a 616.15  |2 23 
245 1 0 |a Myeloproliferative Neoplasms  |h [electronic resource] :  |b Critical Concepts and Management /  |c edited by Tiziano Barbui, Ayalew Tefferi. 
250 |a 1st ed. 2012. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2012. 
300 |a VIII, 240 p. 22 illus., 13 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Hematologic Malignancies,  |x 2197-9766 
505 0 |a Biology -- Gerneral Issues in the Management of MPNs -- Specific Issues of Treatment in PV and ET -- Treatment of PMF -- Research Issues and Perspectives. 
520 |a Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that, under the World Health Organization classification, are subcategorized into eight clinicopathologic entities. The current book focuses on three of these categories: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. A number of important questions regarding the diagnosis, prognosis, and treatment of these diseases have arisen following the discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative MPNs.   This book comprises evidence-based reviews and expert consensus results. It offers comprehensive coverage of relevant laboratory and clinical advances and places great emphasis on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic  approaches, the value and limitations of mutation screening for diagnostic and  prognostic purposes, risk stratification in terms of both survival and other  disease complications such as leukemic transformation and thrombosis, and  modern therapeutic strategies, including conventional drugs, allogeneic stem cell  transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field. 
650 0 |a Hematology. 
650 0 |a Internal medicine. 
650 0 |a Oncology  . 
650 1 4 |a Hematology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 
650 2 4 |a Internal Medicine.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33002 
650 2 4 |a Oncology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160 
700 1 |a Barbui, Tiziano.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Tefferi, Ayalew.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642249884 
776 0 8 |i Printed edition:  |z 9783642249907 
776 0 8 |i Printed edition:  |z 9783662520277 
830 0 |a Hematologic Malignancies,  |x 2197-9766 
856 4 0 |u https://doi.org/10.1007/978-3-642-24989-1 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)